| 臺大學術典藏 |
2022-04-21T06:51:55Z |
Update of the Swedish two-county trial of breast cancer screening: Histologic grade-specific and age-specific results
|
Tabar L.; Vitak B.; Chen, Tony Hsiu Hsi; Prevost T.C.; Duffy S.W. |
| 臺大學術典藏 |
2022-04-21T06:51:54Z |
The natural history of breast carcinoma: What have we learned from screening?
|
Tabár L.; Duffy S.W.; Vitak B.; Chen, Tony Hsiu Hsi; Prevost T.C. |
| 臺大學術典藏 |
2022-04-21T06:51:53Z |
The Swedish two-county trial twenty years later: Updated mortality results and new insights from long-term follow-up
|
Tabár L.; Vitak B.; Chen, Tony Hsiu Hsi; Duffy S.W.; Yen M.-F.; Chiang C.-F.; Krusemo U.B.; Tot T.; Smith R.A. |
| 臺大學術典藏 |
2022-04-21T06:51:50Z |
Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes
|
Duffy S.W.; Cuzick J.; Tabar L.; Vitak B.; Chen, Tony Hsiu Hsi; Yen M.-F.; Smith R.A. |
| 臺大學術典藏 |
2022-04-21T06:51:48Z |
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease
|
Duffy S.W.; Tabar L.; Vitak B.; Day N.E.; Smith R.A.; Chen, Tony Hsiu Hsi; Yen M.F.A. |
| 臺大學術典藏 |
2022-04-21T06:51:48Z |
All-cause mortality among breast cancer patients in a screening trial: Support for breast cancer mortality as an end point
|
Tabar L.; Duffy S.W.; Yen M.-F.; Warwick J.; Vitak B.; Chen, Tony Hsiu Hsi; Smith R.A. |
| 臺大學術典藏 |
2022-04-21T06:51:48Z |
Mammographic screening: A key factor in the control of breast cancer
|
Tabár L.; Smith R.A.; Vitak B.; Yen M.-F.; Chen, Tony Hsiu Hsi; Warwick J.; Myles J.P.; Duffy S.W. |
| 臺大學術典藏 |
2022-04-21T06:51:46Z |
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening
|
Tabar L.; Yen M.-F.; Vitak B.; Tony Chen, Tony Hsiu Hsi; Smith R.A.; Duffy S.W. |
| 臺大學術典藏 |
2022-04-21T06:51:45Z |
The Swedish two-county trial of mammographic screening: Cluster randomisation and end point evaluation
|
Duffy S.W.; Tabar L.; Vitak B.; Yen M.F.; Warwick J.; Smith R.A.; Chen, Tony Hsiu Hsi |
| 臺大學術典藏 |
2022-04-21T06:51:41Z |
Number needed to screen: Lives saved over 20 years of follow-up in mammographic screening
|
Tabar L.; Vitak B.; Yen M.F.A.; Chen, Tony Hsiu Hsi; Smith R.A.; Duffy S.W. |
| 臺大學術典藏 |
2022-04-21T06:51:05Z |
Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England
|
Duffy S.W.; Tabar L.; Olsen A.H.; Vitak B.; Allgood P.C.; Chen, Tony Hsiu Hsi; Yen A.M.F.; Smith R.A. |
| 臺大學術典藏 |
2022-04-21T06:51:03Z |
Duffy and colleagues reply
|
Duffy S.W.; Tabar L.; Olsen A.H.; Vitak B.; Allgood P.C.; Chen, Tony Hsiu Hsi; Yen A.M.F.; Smith R.A. |
| 臺大學術典藏 |
2022-04-21T06:51:01Z |
Cancer mortality in the 50 - 69 year age group before and after screening
|
Duffy S.W.; Tabar L.; Olsen A.H.; Vitak B.; Allgood P.C.; Chen, Tony Hsiu Hsi; Yen A.M.; Smith R.A. |
| 臺大學術典藏 |
2018-09-10T08:05:23Z |
Duffy and colleagues reply
|
Duffy, S.W.;Tabar, L.;Olsen, A.H.;Vitak, B.;Allgood, P.C.;Chen, T.H.H.;Yen, A.M.F.;Smith, R.A.; HSIU-HSI CHEN |
| 臺大學術典藏 |
2018-09-10T07:23:15Z |
Update of the Swedish two-county trial of breast cancer screening: Histologic grade-specific and age-specific results
|
Tabar, L.;Vitak, B.;Chen, H.-H.;Prevost, T.C.;Duffy, S.W.; HSIU-HSI CHEN |
| 臺大學術典藏 |
2018-09-10T07:23:15Z |
The natural history of breast carcinoma: What have we learned from screening?
|
Tab?r, L.;Duffy, S.W.;Vitak, B.;Chen, H.-H.;Prevost, T.C.; HSIU-HSI CHEN |
| 臺大學術典藏 |
2018-09-10T04:44:42Z |
Number needed to screen: Lives saved over 20 years of follow-up in mammographic screening
|
Smith, RA; Duffy, SW; Chen, THH; Yen, MF; Tabar, L.;Vitak, B.;Yen, M.F.A.;Chen, H.H.T.;Smith, R.A.;Duffy, S.W.; Tabar, L; HSIU-HSI CHEN; Vitak, B |
| 臺大學術典藏 |
2018-09-10T04:25:55Z |
Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening
|
HSIU-HSI CHEN; Yen, M.-F.;Tab?r, L.;Vitak, B.;Smith, R.A.;Chen, H.-H.;Duffy, S.W. |
| 臺大學術典藏 |
2018-09-10T04:25:55Z |
Mammographic screening: A key factor in the control of breast cancer
|
Tab?r, L.;Smith, R.A.;Vitak, B.;Yen, M.-F.;Chen, T.H.-H.;Warwick, J.;Myles, J.P.;Duffy, S.W.; HSIU-HSI CHEN |
| 臺大學術典藏 |
2018-09-10T04:25:54Z |
The Swedish two-county trial of mammographic screening: Cluster randomisation and end point evaluation
|
Duffy, S.W.;Tabar, L.;Vitak, B.;Yen, M.F.;Warwick, J.;Smith, R.A.;Chen, H.H.; HSIU-HSI CHEN |
| 臺大學術典藏 |
2018-09-10T04:25:54Z |
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease
|
Duffy, S.W.;Tabar, L.;Vitak, B.;Day, N.E.;Smith, R.A.;Chen, H.H.T.;Yen, M.F.A.; HSIU-HSI CHEN |
| 臺大學術典藏 |
2018-09-10T04:06:01Z |
Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes
|
Duffy, S.W.;Cuzick, J.;Tabar, L.;Vitak, B.;Chen, T.H.-H.;Yen, M.-F.;Smith, R.A.; HSIU-HSI CHEN; Duffy, SW; Cuzick, J; Tabar, L; Vitak, B; Chen, THH; Yen, MF; Smith, RA |
| 臺大學術典藏 |
2018-09-10T03:24:27Z |
The Swedish two-county trial twenty years later: Updated mortality results and new insights from long-term follow-up
|
Tab?r, L.;Vitak, B.;Chen, H.-H.;Duffy, S.W.;Yen, M.-F.;Chiang, C.-F.;Krusemo, U.B.;Tot, T.;Smith, R.A.; HSIU-HSI CHEN |
| 臺北醫學大學 |
2011 |
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades
|
Tab?r, L;Vitak, B;TH, Chen;AM, Yen;Cohen, A;Tot, Tot T;SY, Chiu;LS, Chen;JC, Fann;Rosell, J;Fohlin, H;RA, Smith;SW, Duffy |
| 臺北醫學大學 |
2011 |
Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades
|
Tabar, L;Vitak, B;HH, Chen;AMF, Yen;Cohen, A;Tot, Tot T;SYH, Chiu;SLS, Chen;JCY, Fann;Rosell, J;Fohlin, H;RA, Smith;SW, Duffy |
